Completed

Phase 4
Age: 18Years - 65Years
All Genders
ID00000450

Nalmefene Maintenance Treatment of Alcoholism

Led by The Scripps Research Institute · Updated on 2017-04-20

159

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

T

The Scripps Research Institute

Lead Sponsor

N

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.

CONDITIONS

Official Title

Naltrexone Maintenance Treatment of Alcoholism

Who Can Participate

Age: 18Years - 65Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meets criteria for alcohol dependence.
  • Expresses a desire to cut down or stop drinking.
Not Eligible

You will not qualify if you...

  • Currently meets criteria for dependence on substances other than alcohol.
  • History of opiate dependence or evidence of current opiate use.
  • Significant medical disorders that will increase potential risk or interfere with study participation.
  • Liver function tests more than 3 times normal or elevated bilirubin.
  • Female patients who are pregnant, nursing, or not using a reliable method of birth control.
  • Inability to understand and provide a consent form.
  • Treatment with an investigational drug during the previous month.
  • Prior treatment with naltrexone.
  • Chronic treatment with any narcotic-containing medications during the previous month.
  • Sensitivity to naltrexone as evidenced by adverse drug experiences especially with narcotic containing analgesics or opioid antagonists.
  • Current treatment with disulfiram.
  • More than 6 weeks of abstinence.
  • Meets criteria for a major psychiatric disorder and is in need of, or currently undergoing pharmacotherapy.

Trial Site Locations

Total: 1 location

1

Department of Psychiatry, University of Miami School of Medicine

Miami, Florida, United States, 33136

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

ICONICplus Trial to Study Cannabidiol Plus Naltrexone Effect...

Alcohol Addiction

Actively Recruiting

2 locations

Alcohol and the Social Brain: A Study Using Alcohol Administ...

Alcohol Drinking

Actively Recruiting

2 locations

Alcohol Misuse Treatment Offered in the Liver Clinic to Pati...

Liver Diseases, Alcoholic

Actively Recruiting

1 location

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here